Utilization of a Directly Supervised Telehealth-Based Exercise Training Program in Patients With Nonalcoholic Steatohepatitis: Feasibility Study

Victoria Motz, Alison Faust, Jessica Dahmus, Benjamin Stern, Christopher Soriano, Jonathan G Stine, Victoria Motz, Alison Faust, Jessica Dahmus, Benjamin Stern, Christopher Soriano, Jonathan G Stine

Abstract

Background: Most patients with nonalcoholic fatty liver disease (NAFLD) are physically inactive despite the well-known benefits of physical activity. Telehealth offers promise as a novel way to deliver an exercise training program and increase physical activity. However, the feasibility, safety, and efficacy of telehealth-based exercise programs is unknown in patients with NAFLD.

Objective: The aim of this study was to determine the feasibility of a directly supervised exercise training program delivered exclusively with telehealth to patients with nonalcoholic steatohepatitis (NASH), the progressive form of NAFLD.

Methods: In response to COVID-19 research restrictions, we adapted an existing clinical trial and delivered 20 weeks of moderate-intensity aerobic training 5 days a week under real-time direct supervision using an audio-visual telehealth platform. Aerobic training was completed by walking outdoors or using a home treadmill. Fitness activity trackers with heart rate monitors ensured exercise was completed at the prescribed intensity with real-time feedback from an exercise physiologist.

Results: Three female patients with biopsy-proven NASH were enrolled with a mean age of 52 (SD 14) years. The mean body mass index was 31.9 (SD 5.1) kg/m2. All patients had metabolic syndrome. All patients completed over 80% of exercise sessions (mean 84% [SD 3%]) and no adverse events occurred. Body weight (mean -5.1% [SD 3.7%]), body fat (mean -4.4% [SD 2.3%]), and waist circumference (mean -1.3 in. [SD 1.6 in.]) all improved with exercise. The mean relative reduction in magnetic resonance imaging-proton density fat fraction (MRI-PDFF) was 35.1% (SD 8.8%). Mean reductions in hemoglobin A1c and Homeostatic Model Assessment for Insulin Resistance were also observed (-0.5% [SD 0.2%] and -4.0 [SD 1.2], respectively). The mean peak oxygen consumption (VO2peak) improved by 9.9 (SD 6.6) mL/kg/min.

Conclusions: This proof-of-concept study found that supervised exercise training delivered via telehealth is feasible and safe in patients with NASH. Telehealth-based exercise training also appears to be highly efficacious in patients with NASH, but this will need to be confirmed by future large-scale trials.

Trial registration: ClinicalTrials.gov NCT03518294; https://ichgcp.net/clinical-trials-registry/NCT03518294.

Keywords: aerobic training; fatty liver; fatty liver disease; feasibility; fitness; liver; liver disease; nonalcoholic fatty liver disease; physical activity; steatohepatitis; telehealth; telemedicine.

Conflict of interest statement

Conflicts of Interest: None declared.

©Victoria Motz, Alison Faust, Jessica Dahmus, Benjamin Stern, Christopher Soriano, Jonathan G Stine. Originally published in JMIR Formative Research (https://formative.jmir.org), 17.08.2021.

Figures

Figure 1
Figure 1
Observed clinical benefits of a supervised 20-week telehealth-delivered exercise training program. (A) All patients reduced MRI-PDFF-measured liver fat with exercise training. (B) Exercise training reduced body weight in all patients. (C) Cardiorespiratory fitness improved in all patients (mean VO2 peak +9.9 [SD 6.6] mL/kg/min). (D) Waist circumference was reduced by a mean 1.3 (SD 1.6) in. MRI-PDFF: magnetic resonance imaging proton density fat fraction; VO2 peak: peak oxygen consumption.

References

    1. Stine JG, Soriano C, Schreibman I, Rivas G, Hummer B, Yoo E, Schmitz K, Sciamanna C. Breaking Down Barriers to Physical Activity in Patients with Nonalcoholic Fatty Liver Disease. Dig Dis Sci. 2020 Oct 23;:e1. doi: 10.1007/s10620-020-06673-w.
    1. Thorp A, Stine JG. Exercise as Medicine: The Impact of Exercise Training on Nonalcoholic Fatty Liver Disease. Curr Hepatol Rep. 2020 Dec 09;19(4):402–411. doi: 10.1007/s11901-020-00543-9.
    1. Lin AL, Vittinghoff E, Olgin JE, Pletcher MJ, Marcus GM. Body Weight Changes During Pandemic-Related Shelter-in-Place in a Longitudinal Cohort Study. JAMA Netw Open. 2021 Mar 01;4(3):e212536. doi: 10.1001/jamanetworkopen.2021.2536.
    1. Stine JG, Schreibman I, Navabi S, Kang M, Dahmus J, Soriano C, Rivas G, Hummer B, Beyer M, Tressler H, Kimball SR, Patterson AD, Schmitz K, Sciamanna C. Nonalcoholic steatohepatitis Fitness Intervention in Thrombosis (NASHFit): Study protocol for a randomized controlled trial of a supervised aerobic exercise program to reduce elevated clotting risk in patients with NASH. Contemp Clin Trials Commun. 2020 Jun;18:100560. doi: 10.1016/j.conctc.2020.100560.
    1. Kruger C, McNeely ML, Bailey RJ, Yavari M, Abraldes JG, Carbonneau M, Newnham K, DenHeyer V, Ma M, Thompson R, Paterson I, Haykowsky MJ, Tandon P. Home Exercise Training Improves Exercise Capacity in Cirrhosis Patients: Role of Exercise Adherence. Sci Rep. 2018 Jan 08;8(1):99. doi: 10.1038/s41598-017-18320-y. doi: 10.1038/s41598-017-18320-y.
    1. Pfirrmann D, Huber Y, Schattenberg JM, Simon P. Web-Based Exercise as an Effective Complementary Treatment for Patients With Nonalcoholic Fatty Liver Disease: Intervention Study. J Med Internet Res. 2019 Jan 02;21(1):e11250. doi: 10.2196/11250.
    1. Lim SL, Johal J, Ong KW, Han CY, Chan YH, Lee YM, Loo WM. Lifestyle Intervention Enabled by Mobile Technology on Weight Loss in Patients With Nonalcoholic Fatty Liver Disease: Randomized Controlled Trial. JMIR Mhealth Uhealth. 2020 Apr 13;8(4):e14802. doi: 10.2196/14802.

Source: PubMed

Подписаться